StockData
OKYO Pharma Ltd logo

OKYO Pharma Ltd (OKYO) stock

OKYONasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026Score 1/30
$1.18−0.18 (-12.96%)

Close on Nov 16, 2026Market cap $61.66MP/E –Yield –

OKYO Pharma total assets

Total assets on the balance sheet at the end of each period.

OKYO Pharma's total assets was $20.98M at Mar 31, 2026. For fiscal 2026 it was $20.98M, up 470.4% from the year before. The highest annual figure on record is $20.98M in fiscal 2026.

Annual total assets

PeriodPeriod endValueChange
FY2026Mar 31, 2026$20.98M+470.4%
FY2025Mar 31, 2025$3.68M+138.6%
FY2024Mar 31, 2024$1.54M-70.4%
FY2023Mar 31, 2023$5.20M+21.0%
FY2022Mar 31, 2022$4.30M-39.4%
FY2021Mar 31, 2021$7.09M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ1 2026Mar 31, 2026$20.98M+387.8%
Q4 FY2025CQ1 2025Mar 31, 2025$3.68M-48.1%
Q4 FY2024CQ1 2024Mar 31, 2024$1.54M–
Q4 FY2023CQ1 2023Mar 31, 2023$5.20M–
Q4 FY2022CQ1 2022Mar 31, 2022$4.30M–
Q4 FY2021CQ1 2021Mar 31, 2021$7.09M–

More OKYO Pharma figures

See a number that looks wrong?